American Society of Hematology (ASH)/LinkedIn
May 2, 2026, 15:27
Understanding Localized Intravascular Coagulopathy in Vascular Malformations – ASH
American Society of Hematology (ASH) shared a post on LinkedIn:
”As our knowledge of the pathophysiology of vascular malformations expands, treatment approaches have broadened to include specific targeted therapies based on genetic profiling, with clinical trials ongoing.
Stay informed with Haemostasis Today.
-
May 2, 2026, 15:16William Aird: When Platelets Rise in Infection
-
May 2, 2026, 15:16Emmanuel J. Favaloro: Clinical Challenges in Hemostasis Assessment for Suspected VTE and PE in Emergency Care
-
May 2, 2026, 15:15Chokri Ben Lamine: High-Yield Pearls from a Heme Perspective on Uremic Coagulopathy
-
May 2, 2026, 15:13Apply to Lead a Scientific Workshop at ASH26 – ASH
-
May 2, 2026, 15:11Vitamin C Testing May Be Worth Considering In BDUC- RPTH Journal
-
May 2, 2026, 15:08Ramy Riad: Advancing Plasma-Derived Therapies Through Partnership
-
May 2, 2026, 15:08Ethology and Treatment of Iron Deficiency – Sociedad Iberoamericana de Patient Blood Management
-
May 2, 2026, 14:56Navigating Surgical Bleed Risk in Anticoagulation Management – Thrombosis Canada
-
May 2, 2026, 14:42Gareth Owens: EACTS Aortic Webinar on Heritable Thoracic Aortic Disease and Marfan Syndrome